BIRC5 and neoplasm: In addition, the response of CANX, BID, NAMPT, and BIRC5 with different expression levels to immune checkpoint inhibitors was predicted based on Tumor Immune Dysfunction and Exclusion (TIDE) algorithm (Figures 8B–H).